SCLC patients with ES disease had significantly higher percentages of CD3+CD8+PD-1+ (p = 0.041) as well as CD3+CD4+PD-1+ (p = 0.0029) T-cells compared to HD. The gene discussed is CD4; the disease is small cell lung carcinoma.